Gamma Wave Stimulation for Parkinson's Disease

"This clinical trial is seeking 40 people with idiopathic Parkinson's disease between the ages of 45 and 90. In order to be a successful candidate, they must meet certain criteria such as: being Hoehn & Yahr stage 2-3; having a Montreal Cognitive Assessment (MOCA) score of at least 26 points; speaking, reading and understanding English fluently; providing informed written consent for study participation; getting an MRI or CT scan before recruitment to rule out any structural lesions in the brain; maintaining stable doses of antiparkinsonian medications for one month prior to baseline visit."

"Yes, according to the information on clinicaltrials.gov this trial is currently accepting participants. It was first posted on February 9th 2022 and last updated February 24th 2022. 40 patients across one medical centre must be recruited for the study's completion."

"This medical trial has set the age range for eligible participants to be between 45 and 90. For those younger than 18 years of age, there are 27 studies available whereas 487 studies exist for those older than 65."

"Affirmative. According to clinicaltrials.gov, this research endeavour is still actively seeking out potential participants. It was first registered on February 9th 2022 and the last update took place on February 24th 2022. The study requires 40 recruits from a single medical centre for completion."